# Pantoprazole

## Pantoloc I.V. inj 40 mg

#### 一般可用

| 藥品代碼       | IPAN4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:---------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Maintenance therapy of Erosive esophagitis. Gastroesophageal reflux disease. Gastric hypersecretion， Pathological. Zollinger-Ellison syndrome.                                                                                                                                                                                                                                                                                                                                                                                                       |
| 用法用量       | 40 mg IV infusion once daily for 7 days. Discontinue IV therapy as soon as the patient is able to receive treatment with oral pantoprazole. Zollinger-Ellison syndrome: Initial， 80 mg/day; may increase to 160 mg/day; doses up to 80 mg daily have been divided into twice daily for a limited period of time.                                                                                                                                                                                                                                     |
| 肝功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 禁忌           | Known hypersensitivity including anaphylaxis， anaphylactic shock， angioedema， bronchospasm， acute tubulointerstitial nephritis， and urticaria to substituted benzimidazoles or any component of the product. Concomitant use with rilpivirine-containing products.                                                                                                                                                                                                                                                                               |
| 副作用         | Common Gastrointestinal: Abdominal pain (3% )， Diarrhea (4% )， Flatulence (4% ) Neurologic: Headache (5% ) Serious Dermatologic: Cutaneous lupus erythematosus Gastrointestinal: Atrophic gastritis， Clostridium difficile diarrhea， Fundic gland polyposis of stomach Hematologic: Thrombocytopenia (less than 1% ) Immunologic: Stevens-Johnson syndrome， Toxic epidermal necrolysis Musculoskeletal: Disorder of muscle， Fracture of bone， Osteoporosis-related， Hip fracture， Rhabdomyolysis Renal: Tubulointerstitial nephritis， acute |
| 孕期用藥建議   | Human data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

